Canada markets closed

ALUR Jul 2024 7.500 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
6.050.00 (0.00%)
As of 09:56AM EDT. Market open.
Full screen
Previous Close6.05
Open6.05
Bid6.10
Ask6.80
Strike7.50
Expire Date2024-07-19
Day's Range6.05 - 6.05
Contract RangeN/A
Volume20
Open Interest23
  • Business Wire

    Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement

    NATICK, Mass., June 28, 2024--Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a company dedicated to ending obesity, today announced the pricing of an underwritten public offering of 14,406,508 shares of its common stock, par value $0.0001 per share (the "Shares"), and warrants to purchase 14,406,508 Shares (the "Warrants" and, together with the Shares, the "Securities") at a public offering price of $1.20 per share, for total gross proceeds of $17.3 million, before deduc

  • Business Wire

    Allurion Announces Launch of Offering of Common Stock and Warrants

    NATICK, Mass., June 26, 2024--Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a company dedicated to ending obesity, today announced that it has launched an underwritten public offering of up to $20 million of its common stock, par value $0.0001 per share (the "Shares"), and warrants to purchase Shares (the "Warrants" and, together with the Shares, the "Securities").

  • Business Wire

    Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss

    NATICK, Mass., June 20, 2024--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the publication of a study demonstrating an average lean mass gain of 5.6% in patients with an average weight loss of 14% at four months on the Allurion Program. Vital signs and physical activity were tracked in real-time with the Allurion App, Connected Scale, and Health Tracker, and follow-up was provided through the AI-powered Allurion Virtual Care Suite.